405 filings
6-K
IPCIF
Intellipharmaceutics International Inc.
5 Dec 19
Primary Document
9:36am
6-K
IPCIF
Intellipharmaceutics International Inc.
25 Nov 19
Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. for Venlafaxine ER
4:39pm
SC 13D/A
IPCIF
Intellipharmaceutics International Inc.
18 Nov 19
Intellipharmaceutics International Inc.
5:03pm
6-K
IPCIF
Intellipharmaceutics International Inc.
18 Nov 19
Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing
4:38pm
6-K
IPCIF
Intellipharmaceutics International Inc.
7 Nov 19
Intellipharmaceutics Announces Settlement Agreement in Class Action Lawsuit, Which is Subject to Court Approval
4:20pm
6-K
2szcmze 0d44ps
24 Oct 19
Intellipharmaceutics Update on its Oxycodone ER New Drug Application
1:48pm
6-K
l03xsanaf6
11 Oct 19
Primary Document
5:20pm
6-K
4z641o3lj890g
4 Oct 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
8:07am
6-K
vhz3t6npwivs1xves4
5 Sep 19
Primary Document
1:44pm
6-K
ydsbn4 j9refuhm
15 Aug 19
Primary Document
3:28pm
6-K
sg8t1sk3ymd
24 Jul 19
Update on its Oxycodone ER New Drug Application
5:13pm
6-K
warrd7kpuqh5k1
10 Jul 19
Primary Document
5:08pm
6-K
kn5ghsdg46i1or2uwg
8 Jul 19
Primary Document
5:18pm
25-NSE
d7qvy92 ul
3 Jun 19
Exchange delisting
9:59am
6-K
h493e3c8ata3lsrj1z
30 May 19
Intellipharmaceutics Announces Receipt of Cannabis Drug License from Health Canada
8:51am
6-K
wrgi2i 1b
29 May 19
Intellipharmaceutics Reports Director Election Results
5:07pm
424B3
1s6jld304s i65t
29 May 19
Prospectus supplement
3:18pm
424B3
airzzddu
29 May 19
Prospectus supplement
3:13pm
6-K
7ov8 7kdmuza
29 May 19
Intellipharmaceutics to present at the 9th Annual LD Micro Invitational
9:38am
6-K
9d78ig5g zhz82
28 May 19
Annual & Special Meeting of Shareholders
4:41pm